These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7081978)

  • 21. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight ("pharmacokinetic mass").
    Shibutani K; Inchiosa MA; Sawada K; Bairamian M
    Anesthesiology; 2004 Sep; 101(3):603-13. PubMed ID: 15329584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint.
    Diepstraten J; Janssen EJ; Hackeng CM; van Dongen EP; Wiezer RJ; van Ramshorst B; Knibbe CA
    Eur J Clin Pharmacol; 2015 Jan; 71(1):25-34. PubMed ID: 25304008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Fixed versus Weight-Based Dosing Strategy of Daptomycin May Improve Safety in Obese Adults.
    Butterfield-Cowper JM; Lodise TP; Pai MP
    Pharmacotherapy; 2018 Sep; 38(9):981-985. PubMed ID: 29906315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Obesity on Anti-Xa Concentrations in Bariatric Patients.
    Schijns W; Deenen MJ; Aarts EO; Homan J; Janssen IMC; Berends FJ; Kaasjager KAH
    Obes Surg; 2018 Jul; 28(7):1997-2005. PubMed ID: 29404935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults.
    Pai MP
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4585-9. PubMed ID: 27185808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers.
    Smithers JA; Kulmala HK; Thompson GA; Antony KK; Lewis EW; Ruberg SJ; Kenny MT; Dulworth JK; Brackman MA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):115-20. PubMed ID: 1534211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients.
    Shibutani K; Inchiosa MA; Sawada K; Bairamian M
    Br J Anaesth; 2005 Sep; 95(3):377-83. PubMed ID: 16024584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.
    Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Roger C; Udy AA; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery.
    Wittau M; Paschke S; Kurlbaum M; Scheele J; Ly NS; Hemper E; Kornmann M; Henne-Bruns D; Bulitta JB
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine pharmacokinetics in obese and lean subjects.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Ann Pharmacother; 1995 Sep; 29(9):843-7. PubMed ID: 8547729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ranitidine in morbidly obese women.
    Davis RL; Quenzer RW; Bozigian HP; Warner CW
    DICP; 1990 Nov; 24(11):1040-3. PubMed ID: 2275223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
    Blevins RD; Halstenson CE; Salem NG; Matzke GR
    Antimicrob Agents Chemother; 1984 May; 25(5):603-6. PubMed ID: 6732227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults.
    Wasmann RE; Ter Heine R; van Dongen EP; Burger DM; Lempers VJ; Knibbe CA; Brüggemann RJ
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity effects on nitrazepam disposition.
    Abernethy DR; Greenblatt DJ; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Nov; 22(5):551-7. PubMed ID: 3790401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity, sex, and acetaminophen disposition.
    Abernethy DR; Divoll M; Greenblatt DJ; Ameer B
    Clin Pharmacol Ther; 1982 Jun; 31(6):783-90. PubMed ID: 7075126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prednisolone disposition in obese men.
    Milsap RL; Plaisance KI; Jusko WJ
    Clin Pharmacol Ther; 1984 Dec; 36(6):824-31. PubMed ID: 6499362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.
    Dvorchik BH; Damphousse D
    J Clin Pharmacol; 2005 Jan; 45(1):48-56. PubMed ID: 15601805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cimetidine clearance in the obese.
    Bauer LA; Wareing-Tran C; Edwards WA; Raisys V; Ferreri L; Jack R; Dellinger EP; Simonowitz D
    Clin Pharmacol Ther; 1985 Apr; 37(4):425-30. PubMed ID: 3979004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.
    Chung EK; Cheatham SC; Fleming MR; Healy DP; Kays MB
    J Clin Pharmacol; 2017 Mar; 57(3):356-368. PubMed ID: 27530916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiopental disposition in lean and obese patients undergoing surgery.
    Jung D; Mayersohn M; Perrier D; Calkins J; Saunders R
    Anesthesiology; 1982 Apr; 56(4):269-74. PubMed ID: 7065435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.